327 related articles for article (PubMed ID: 16439535)
1. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
Gammoh N; Grm HS; Massimi P; Banks L
J Virol; 2006 Feb; 80(4):1787-97. PubMed ID: 16439535
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
Avvakumov N; Torchia J; Mymryk JS
Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
Massimi P; Pim D; Banks L
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein.
Grm HS; Massimi P; Gammoh N; Banks L
Oncogene; 2005 Aug; 24(33):5149-64. PubMed ID: 15856010
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells.
Wu MH; Chan JY; Liu PY; Liu ST; Huang SM
Int J Biochem Cell Biol; 2007; 39(2):413-25. PubMed ID: 17092759
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
8. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
9. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
Hermonat PL; Santin AD; Zhan D
J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
11. The HPV16 E2 transcriptional regulator mode of action depends on the physical state of the viral genome.
Schmidt MT; Olejnik AK; Goździcka-Józefiak A
Acta Biochim Pol; 2005; 52(4):823-32. PubMed ID: 16273126
[TBL] [Abstract][Full Text] [Related]
12. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
13. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
14. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2.
Okoye A; Cordano P; Taylor ER; Morgan IM; Everett R; Campo MS
Virus Res; 2005 Mar; 108(1-2):1-14. PubMed ID: 15681049
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
18. Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene.
Jakubícková L; Baráthová M; Pastoreková S; Pastorek J; Gibadulinová A
Acta Virol; 2005; 49(2):133-7. PubMed ID: 16047742
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
20. Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system.
Garner-Hamrick PA; Fostel JM; Chien WM; Banerjee NS; Chow LT; Broker TR; Fisher C
J Virol; 2004 Sep; 78(17):9041-50. PubMed ID: 15308700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
